Bone mineral density of the left femoral neck in lymphoma survivors treated with high dose therapy with autologous stem cell support.

被引:0
|
作者
Seland, Mette
Smeland, Knut Halvor B.
Holte, Harald
Bjoero, Trine
Godang, Kristin
Bollerslev, Jens
Fossa, Sophie D.
Kiserud, Cecilie E.
机构
[1] Oslo Univ Hosp, Natl Advisory Unit Late Effects, Div Surg & Canc Med, Oslo, Norway
[2] Oslo Univ Hosp, Natl Advisory Unit Late Effects Canc Treatment, Oslo, Norway
[3] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[4] Norwegian Radium Hosp, Oslo Univ Hosp, Oslo, Norway
[5] Oslo Univ Hosp, Sect Specialized Endocrinol, Oslo, Norway
[6] Oslo Univ Hosp, Oslo, Norway
[7] Univ Oslo, Oslo, Norway
[8] Oslo Univ Hosp, Natl Advisory Unit Late Effects, Dept Oncol, Oslo, Norway
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20612
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
    Seland, Mette
    Smeland, Knut B.
    Bjoro, Trine
    Falk, Ragnhild S.
    Fossa, Sophie D.
    Gjesdal, Clara G.
    Godang, Kristin
    Holte, Harald
    Svartberg, Johan
    Syversen, Unni
    Bollerslev, Jens
    Kiserud, Cecilie E.
    ACTA ONCOLOGICA, 2017, 56 (04) : 590 - 598
  • [2] Does high dose therapy with autologous stem cell transplantation affect bone mineral density in patients with lymphoma?
    Fredriksson, R.
    Lewerin, C.
    Johansson, P.
    Mellstrom, D.
    Kristjansdottir, H. Lind
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 303 - 303
  • [3] Immune reconstitution after high dose therapy with autologous blood stem cell support.
    Steingrimsdottir, H
    Gruber, A
    Bjorkholm, M
    Svensson, A
    Hansson, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S130 - S130
  • [4] Grading of mucositis in patients receiving high-dose therapy with autologous or allogeneic stem cell support.
    Borén, S
    Berndtson, M
    Gustavsson, C
    Juliusson, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S247 - S247
  • [5] Psychological evaluation of patients treated with high dose chemotherapy and autologous peripheral stem cells support.
    Orlando, L
    Gadda, B
    Casellato, L
    Bredart, A
    Didier, F
    Roveda, L
    Colombi, FB
    Scaffidi, E
    Di Leverano, C
    Magri, R
    Compare, L
    Labò, M
    Cocquio, A
    Peccatori, F
    Cinieri, S
    Ferrucci, PF
    Martinelli, G
    BONE MARROW TRANSPLANTATION, 1999, 23 : S258 - S258
  • [6] Advancement in high dose therapy and autologous stem cell rescue in lymphoma
    Isidori, Alessandro
    Clissa, Cristina
    Loscocco, Federica
    Guiducci, Barbara
    Barulli, Sara
    Malerba, Lara
    Gabucci, Elisa
    Visani, Giuseppe
    WORLD JOURNAL OF STEM CELLS, 2015, 7 (07): : 1039 - 1046
  • [7] Gene transfer to improve high-dose chemotherapy with autologous hematopoietic stem cell support.
    Symann, M
    DHondt, V
    Guillaume, T
    Govaerts, AS
    Bank, A
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 379 - 379
  • [8] High dose therapy and autologous stem cell transplantation in mantle cell lymphoma
    Hiddemann, W
    Dreyling, M
    Parwaresch, R
    Unterhalt, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 49
  • [9] Erythropoietin decreases transfusion requirements in patients with relapsed lymphoma treated with the Cologne high-dose sequential chemotherapy regimen prior to autologous stem cell support.
    Josting, A
    Glossmann, JP
    Wassmer, G
    Flechtner, H
    Ko, Y
    Rudolph, C
    Illiger, HJ
    Dorken, B
    Wiedenmann, S
    Diehl, V
    Engert, A
    BLOOD, 2001, 98 (11) : 300A - 300A
  • [10] Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support
    Kastritis, Efstathios
    Terpos, Evangelos
    Anagnostopoulos, Athanasios
    Xilouri, Irini
    Dimopoulos, Meletios Athanasios
    CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (01): : 73 - 76